Search Result

Learn about Drug Eutectic Screening The selection of solid forms of drugs is an important factor to be considered in the study of drug preparations. The solid form of drugs mainly includes polycrystalline form, salt, hydrate or solvate,...
Optimizing Polymer Selection for Amorphous Solid Dispersion in Hot Melt Extrusion Processes
19th WRIB (Workshops on Recent Issues in Bioanalysis)  Crystal Bio Solutions, a member of Crystal Pharmatech, is excited to be at Booth 80 – ready to talk all things bioanalysis and biomarkers! From early discovery through BLA, our GLP-compliant labs and...
Crystal Pharmatech Raises $10 Million to Accelerate Growth On September 15, 2015, Crystal Pharmatech Co., Ltd. Announced the completion of raising $10 million in Series A funding led by Renner Lian he Holdings. Crystal Pharmatech will use the funds to further...
Crystallization Process Method Crystallization is the process by which a substance is precipitated in a crystalline state from a vapor, solution, or molten substance. When drugs crystallize, if different solvents and processes are ...
DCAT Week 2025 Crystal Pharmatech is Heading to DCAT Week 2025! Meet Our Leadership Team. We’re excited to be in New York City from March 17-20 for DCAT Week 2025! Our leadership team will be there to connect and ...
Solid State Characterization: Techniques, Standards, and Verified Data—An Integrated Lens for CMC Development
Sitemap 123
Crystal Formulation Services, Formulation Tailor-made for Your Molecules Crystal Pharmatech, the leading solid state research CRO, is proud to announce the opening of a novel, small molecule, formulation CDMO subsidiary known as Crystal Formulation Services (CFS).Crystal P...
Fun Sharing: The Secret Behind the Silky Smoothness of Chocolate (Part 2) The story behind the perfect chocolateThe control of the crystal structure V's nucleation, growth, and stability in the polymorphic system, which is so close and easy to transform each other, has ...
Amorphous Solid Dispersions: Two Heads Are Better Than One Speaker: Dr. Na Li, Assistant Professor in Pharmaceutical Sciences at the University of Connecticut

Amorphous solid dispersion is an important formulation strategy used to overcome a drug’s poor solubility and boost bioavailability. Through molecular mixing with a polymer in the amorphous state, the drug’s dissolution rate is greatly enhanced. This does not only lead to increased free drug concentration in solution, but also sometimes the generation of amorphous drug nanoparticles.
AAPS 2024 PHarmSCi 360 Meet with industry leadership to discuss:Developability AssessmentAPI Form and Solid-State ResearchFormulation DevelopmentClinical and Commercial ManufacturingBiologics Analytical ServicesDate: Octobe...
Concerned about mRNA -LNP Integrity during International Shipping?